Error: Could not add to watchlist. X

Insys Therapeutics Inc

+ Watchlist
INSY:US
NASDAQ GM
35.92
USD
1.26
3.64%
As of 19:40:00 ET on 06/30/2015.
Open
35.03
Day Range
35.03 - 36.24
Volume
1,125,826
Previous Close
34.66
52Wk Range
11.26 - 42.69
1 Yr Return
130.04%
Current P/E Ratio (TTM)
61.46
Earnings per Share (USD) (TTM)
0.58
Market Cap (b USD)
2.566
Shares Outstanding (m)
71.426
Price/Sales (TTM)
9.98
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Insys Therapeutics, Inc. develops cancer support drugs. The Company's support care candidates include a fast-acting sublingual spray for cancer pain, and a dronabinol product used to treat chemotherapy-induced nausea and vomiting and to stimulate appetite in AIDS patients.
ADDRESS
444 South Ellis Street
Chandler, AZ 85224
United States
PHONE
1-602-910-2617
  • John N Kapoor
    Chairman
  • Michael L Babich
    President/CEO
  • Darryl S Baker
    Chief Financial Officer
  • Amy Raskopf
    Investor Relations
  • Franc E Del Fosse
    Secretary/General Counsel
Show More